Sanofi ADS (SNY) Financials Nov 18, 2014, 7:21 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Sanofi ADS
Fiscal year is January-December. All values EUR millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 29.31B 32.37B 33.39B 34.95B 32.95B
Cost of Goods Sold (COGS) incl. D&A 11.45B 13.11B 14.74B 14.47B 13.98B
COGS excluding D&A 6.94B 8.45B 9.64B 9.87B 9.83B
Depreciation & Amortization Expense 4.51B 4.67B 5.09B 4.6B 4.15B
Depreciation 929M 1.09B 1.26B 1.2B 1.14B
Amortization of Intangibles 3.58B 3.58B 3.83B 3.4B 3.01B
Gross Income 17.86B 19.26B 18.65B 20.48B 18.98B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 11.87B 12.51B 13.35B 13.76B 13.3B
Research & Development 4.57B 4.39B 4.81B 4.89B 4.76B
Other SG&A 7.3B 8.12B 8.54B 8.87B 8.54B
Other Operating Expense 480M 291M 315M 185M 241M
Unusual Expense 1.45B 1.82B 1.24B 1.63B 1.2B
EBIT after Unusual Expense (1.45B) (1.82B) (1.24B) (1.63B) (1.2B)
Non Operating Income/Expense 2.23B 1.87B 1.94B 1.29B 775M
Non-Operating Interest Income 88M 61M 100M 68M 49M
Equity in Affiliates (Pretax) - - - - -
Interest Expense 310M 392M 472M 496M 457M
Gross Interest Expense 310M 419M 516M 523M 482M
Interest Capitalized 0 27M 44M 27M 25M
Pretax Income 6.07B 6.17B 5.32B 5.77B 4.6B
Income Tax 1.36B 1.43B 455M 1.11B 763M
Income Tax - Current Domestic 2.53B 2.93B 2.36B 2.05B 1.78B
Income Tax - Current Foreign 0 - - - -
Income Tax - Deferred Domestic (1.17B) (1.5B) (1.9B) (941M) (1.01B)
Income Tax - Deferred Foreign 0 - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 814M 978M 1.07B 393M 35M
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 5.52B 5.72B 5.93B 5.06B 3.88B
Minority Interest Expense 426M 254M 241M 169M 158M
Net Income 5.09B 5.47B 5.69B 4.89B 3.72B
Extraordinaries & Discontinued Operations 175M 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 175M 0 0 0 0
Net Income After Extraordinaries 5.27B 5.47B 5.69B 4.89B 3.72B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 5.09B 5.47B 5.69B 4.89B 3.72B
EPS (Basic) 4.03 4.19 4.31 3.71 2.81
Basic Shares Outstanding 1.31B 1.31B 1.32B 1.32B 1.32B
EPS (Diluted) 4.03 4.18 4.29 3.68 2.78
Diluted Shares Outstanding 1.31B 1.31B 1.33B 1.33B 1.34B
EBITDA 10.02B 11.12B 10.09B 11.13B 9.58B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Sanofi ADS
Fiscal year is January-December. All values EUR millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 29.31B 32.37B 33.39B 34.95B 32.95B
Cost of Goods Sold (COGS) incl. D&A 11.45B 13.11B 14.74B 14.47B 13.98B
COGS excluding D&A 6.94B 8.45B 9.64B 9.87B 9.83B
Depreciation & Amortization Expense 4.51B 4.67B 5.09B 4.6B 4.15B
Depreciation 929M 1.09B 1.26B 1.2B 1.14B
Amortization of Intangibles 3.58B 3.58B 3.83B 3.4B 3.01B
Gross Income 17.86B 19.26B 18.65B 20.48B 18.98B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 11.87B 12.51B 13.35B 13.76B 13.3B
Research & Development 4.57B 4.39B 4.81B 4.89B 4.76B
Other SG&A 7.3B 8.12B 8.54B 8.87B 8.54B
Other Operating Expense 480M 291M 315M 185M 241M
Unusual Expense 1.45B 1.82B 1.24B 1.63B 1.2B
EBIT after Unusual Expense (1.45B) (1.82B) (1.24B) (1.63B) (1.2B)
Non Operating Income/Expense 2.23B 1.87B 1.94B 1.29B 775M
Non-Operating Interest Income 88M 61M 100M 68M 49M
Equity in Affiliates (Pretax) - - - - -
Interest Expense 310M 392M 472M 496M 457M
Gross Interest Expense 310M 419M 516M 523M 482M
Interest Capitalized 0 27M 44M 27M 25M
Pretax Income 6.07B 6.17B 5.32B 5.77B 4.6B
Income Tax 1.36B 1.43B 455M 1.11B 763M
Income Tax - Current Domestic 2.53B 2.93B 2.36B 2.05B 1.78B
Income Tax - Current Foreign 0 - - - -
Income Tax - Deferred Domestic (1.17B) (1.5B) (1.9B) (941M) (1.01B)
Income Tax - Deferred Foreign 0 - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 814M 978M 1.07B 393M 35M
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 5.52B 5.72B 5.93B 5.06B 3.88B
Minority Interest Expense 426M 254M 241M 169M 158M
Net Income 5.09B 5.47B 5.69B 4.89B 3.72B
Extraordinaries & Discontinued Operations 175M 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 175M 0 0 0 0
Net Income After Extraordinaries 5.27B 5.47B 5.69B 4.89B 3.72B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 5.09B 5.47B 5.69B 4.89B 3.72B
EPS (Basic) 4.03 4.19 4.31 3.71 2.81
Basic Shares Outstanding 1.31B 1.31B 1.32B 1.32B 1.32B
EPS (Diluted) 4.03 4.18 4.29 3.68 2.78
Diluted Shares Outstanding 1.31B 1.31B 1.33B 1.33B 1.34B
EBITDA 10.02B 11.12B 10.09B 11.13B 9.58B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
